ketoconazole has been researched along with Ovarian Diseases in 1 studies
1-acetyl-4-(4-{[2-(2,4-dichlorophenyl)-2-(1H-imidazol-1-ylmethyl)-1,3-dioxolan-4-yl]methoxy}phenyl)piperazine : A dioxolane that is 1,3-dioxolane which is substituted at positions 2, 2, and 4 by imidazol-1-ylmethyl, 2,4-dichlorophenyl, and [para-(4-acetylpiperazin-1-yl)phenoxy]methyl groups, respectively.
Ovarian Diseases: Pathological processes of the OVARY.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Ketoconazole therapy was not associated with a change in basal or postgonadotropin-releasing hormone stimulation gonadotropin levels." | 1.28 | Ketoconazole use in the treatment of ovarian hyperandrogenism. ( Brenner, SH; Gabrilove, JL; Pepper, G, 1990) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Pepper, G | 1 |
| Brenner, SH | 1 |
| Gabrilove, JL | 1 |
1 other study available for ketoconazole and Ovarian Diseases
| Article | Year |
|---|---|
Ketoconazole use in the treatment of ovarian hyperandrogenism.
Topics: 17-alpha-Hydroxyprogesterone; Adrenocorticotropic Hormone; Adult; Androgens; Estradiol; Female; Foll | 1990 |